Clinical Trials on Time to First Request of Rescue Analgesics, in Ireland
Total 0 results
Nothing found
Sponsors and Collaborators
- Méthodologie et Evaluation pour la Recherche clinique et Epidémiologique sur le VIH en Afrique (MEREVA)
- The Depressive and Bipolar Disorder Alternative Treatment Foundation
- Laboratoires Iprad-Vegebom
- Resurge Therapeutics Inc.
- Sonogenix
- Jain, Isha, B.A., Massachusetts General Hospital, Harvard Medical School
- Paul W. Read, MD
- Remedy Institute
- Prader-Willi Syndrome Association of Australia
- Brigham and Womens' Hospital, Center for Surgery and Public Health
- wenbinlu
- Kettering Foundation
- Health Holding Company, Hail Health Cluster, Saudi Arabia
- Zhijun Sun
- Dr Gilles DUCHEIX/ Center of clinical pharmacology/CIC Inserm-501 - Investigator
- NATURAmedicatrix Sàrl
- Carlos III Health Institute
- Epicentre, Paris, France.
- Sociedad Española de Arteriosclerosis
- Australian Childhood Foundation
- View Full List
Medical Conditions
- Psychoactive Substance Use
- Intervention Studies
- Pregnancy; Accident
- Refractory B-Lineage Lymphoma
- Escape Room Games and Role Playing Gamification
- Apneic; Oxygenation
- Cell Senescence
- Relapsed/Refractory Diffuse Large B-cell Lymphoma
- Malignant Tumor of Extrahepatic Bile Duct
- Neurobehavioral Manifestation
- Adherence to In-Office Glaucoma Evaluation Appointment
- Spinocerebellar Ataxia Genotype Type 3
- Marginal Zone B-cell Lymphoma
- Mycobacterium Avium Complex Infections
- Stroke Recrudescence
- Ankle Trauma
- Stage III Childhood Anaplastic Large Cell Lymphoma
- Hernia,Ventral
- Lymphoblastic Lymphoma
- Stage IIIB Esophageal Adenocarcinoma
- View Full List
Drug Interventions
- Triple therapy
- Fenofibric acid 135mg
- Low molecular weight Heparin as standard of care treatment
- Epalrestat
- Fostamatinib
- LINjeta U-100 Insulin
- Omeprazole 40 mg
- Irinotecan
- Fortum (Ceftazidime for injection USP) Glaxo Smith Kline Pharmaceuticals Limited
- Everolimus
- Optiva artificial tear by Allergan
- Oral Aztreonam
- SBI-087
- FRSW107
- 300 mg of caffeine citrate infusion
- ART-123
- Atezolizumab (MPDL3280A), an engineered anti-PD-L1 antibody
- Lansoprazole 15mg QD
- Colecalciferol D3 (Vigantol Oil)
- Gadoteridol (ProHance)
- View Full List
CROs by country
- Contract Research Organizations in Algeria
- Contract Research Organizations in Angola
- Contract Research Organizations in Argentina
- Contract Research Organizations in Burundi
- Contract Research Organizations in El Salvador
- Contract Research Organizations in Germany
- Contract Research Organizations in Lebanon
- Contract Research Organizations in Malaysia
- Contract Research Organizations in Mexico
- Contract Research Organizations in Mongolia
- Contract Research Organizations in Togo
- Contract Research Organizations in Trinidad & Tobago
- Contract Research Organizations in United States
- CRO list by country